Abstract:Photodynamic and photothermal therapy (PDT and PTT) have been widely used in tumor treatment researches owe to its advantages of spatiotemporal controlliability and non-invasiveness. Combining two phototherapy strategies together and/or with chemodynamic therapy (CDT) could achieve better therapeutic efficiency, but the resulting inconvenient dual-laser irradiation and the potential skin toxicity limit its development. Moreover, the lack of tumor-specificity causes side-effects to normal tissues. Therefore, shortening the irradiation time, or integrating two lasers, and increasing tumor specificity are necessary to reduce side effects. Herein, we developed a tumor microenvironment responsive one-laser-excited PDT/PTT/CDT synergistic therapeutic nanosystem ZPPSC (refers to ZGGC-PDA-PEI-Si-Pc-Cu) for precise tumor phototherapy. In this nanosystem, the simultaneous PTT and PDT activation using a single laser, enhancing phototherapy efficiency while reducing phototoxicity were achieved. Specifically, persistent luminescence nanoparticle ZnGa 1.6 Ge 0.2 O 4 :Cr (ZGGC) is coated with polydopamine (PDA) through self-polymerization of dopamine, modified with polyethyleneimine (PEI), Si-Pc, and adsorbed with Cu 2+ . Cu 2+ quenches the persistent luminescence (PersL) in physiological environment, and could be reduced to Cu + under the excess GSH in tumor cells, resulting in removing from nanosystem. Whereafter, PersL is restored, and Fenton-like reaction between Cu + and overexpressed H 2 O 2 is triggered to generate ·OH for CDT therapy. Under single 808-nm irradiation, PDA will be irradiated to perform PTT, and the opening persistent luminescence could irradiate photosensitizers for PDT and continues to stimulate them even after the laser stops, reducing external excitation time. The in vivo results shown that ZPPSC exhibit ideal PDT performance, and increased local temperature close to 60 °C. Most importantly, the tumor inhibition rate by combined PTT, PDT, CDT with 5-min 808-nm laser irradiation is 99%, and even one mouse was completely cured with the bearing tumor completely disappeared. By using this nanosystem, PDT and PTT were achieved by only on laser with relatively short irradiation time. Moreover, the weak tissue penetration of the 660-nm PS excitation source was also addressed. Our design achieves tumor-specific one-laser three-mode phototherapy with shortened irradiation time, enhancing therapy effectiveness while minimizing side effects. These results exhibit great therapeutic outcomes of ZPPSC for precious tumor phototherapy.

Tumor Microenvironment Stimuli‐Responsive Single‐NIR‐Laser Activated Synergistic Phototherapy for Hypoxic Cancer by Perylene Functionalized Dual‐Targeted Upconversion Nanoparticles

Tumor Microenvironment Activated Multifunctional Nanoparticles for Precisely Controlled Tumor Photothermal and Photodynamic Therapy

Photothermal-pH-hypoxia Responsive Multifunctional Nanoplatform for Cancer Photo-Chemo Therapy with Negligible Skin Phototoxicity.

Single-laser excitation synergistic photo- and chemodynamic therapy system based on persistent luminescence nanoparticles

Design of the Tumor Microenvironment-Multiresponsive Nanoplatform for Dual-Targeting and Photothermal Imaging Guided Photothermal/photodynamic/chemodynamic Cancer Therapies with Hypoxia Improvement and GSH Depletion

Three birds with one stone: oxygen self-supply engineering palladium nanocluster/titanium carbide hybrid for single-NIR laser-triggered synergistic photodynamic-photothermal therapy

Upconversion Nanoparticles Hybridized Cyanobacterial Cells for Near‐Infrared Mediated Photosynthesis and Enhanced Photodynamic Therapy

Multifunctional Nanoplatform for Single NIR Laser-Regulated Efficient PDT/PTT/Chemotherapy

A Hybrid Nanomaterial with NIR-induced Heat and Associated Hydroxyl Radical Generation for Synergistic Tumor Therapy

An Effective Nir Laser/Tumor-Microenvironment Co-Responsive Cancer Theranostic Nanoplatform With Multi-Modal Imaging And Therapies

Engineered cells-assisted photoactive nanoparticles delivery for image-guided synergistic photodynamic/photothermal therapy of cancer.

NIR-Light-Intensified Hypoxic Microenvironment for Cascaded Supra-Prodrug Activation and Synergistic Chemo/Photodynamic Cancer Therapy

Light/pH Dual Controlled Drug Release "nanocontainer" Alleviates Tumor Hypoxia for Synergistic Enhanced Chemotherapy, Photodynamic Therapy and Chemodynamic Therapy

Near-infrared photosensitizers adaptive to tumor hypoxic microenvironment for synergistic photothermal-photodynamic and immunotherapy

A Triple-Stimulus Responsive Melanin-Based Nanoplatform with an Aggregation-Induced Emission-Active Photosensitiser for Imaging-Guided Targeted Synergistic Phototherapy/hypoxia-Activated Chemotherapy.

Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy

A Near‐Infrared Light‐Responsive ROS Cascade Nanoplatform for Synergistic Therapy Potentiating Antitumor Immune Responses

Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced Phototherapy

Polydopamine Coated PB-MnO2 Nanoparticles as an Oxygen Generator Nanosystem for Imaging-Guided Single-NIR-Laser Triggered Synergistic Photodynamic/Photothermal Therapy

Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy

An Engineered Cascade-Sensitized Red-Emitting Upconversion Nanoplatform with a Tandem Hydrophobic Hydration-Shell and Metal-Phenolic Network Decoration for Single 808 Nm Triggered Simultaneous Tumor PDT and PTT Enhanced CDT.